- Available history
- No dated observations
- Data captured
IPO Date coverage
Aligos Therapeutics, Inc. (ALGS). What the retained company guidance contains and how many periods can be scored.
- Legal name: Value Aligos Therapeutics, Inc..
- Ticker: Value ALGS.
- Exchange: Value Nasdaq.
- IPO date: Value 19 Oct 2020.
| Measure | Value |
|---|---|
| Legal name | Aligos Therapeutics, Inc. |
| Ticker | ALGS |
| Exchange | Nasdaq |
| IPO date | 19 Oct 2020 |
| Country of operation (business address) | United States |
| Final IPO prospectus | Form 424B4 filed 2020-10-19, accession 0001193125-20-272151 |
| Registration statement | Form S-1 filed 2020-09-25, accession 0001193125-20-254760 |
| Current registered country | Delaware, United States SEC EDGAR state of incorporation DE |
| Business address | ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO, California, 94080, United States |
| Mailing address | ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO, California, 94080, United States |
| Industry (SIC) | 2836 Biological Products, (No Diagnostic Substances) |
| Fiscal year end | 12-31 |
| Filer category | Non-accelerated filer<br>Smaller reporting company |
| Listed stock (Section 12(b)) | Common Stock par value, $0.0001 per share · ALGS · NASDAQ 10-Q filed 2026-08-06 cover |
| Shell company | No 10-Q filed 2026-08-06 cover |
| Smaller reporting company | Yes 10-Q filed 2026-08-06 cover |
| Emerging growth company | No 10-Q filed 2026-08-06 cover |
| Current in its reporting | Yes 10-Q filed 2026-08-06 cover |
| Well-known seasoned issuer | No 10-K filed 2026-03-05 cover |
| Voluntary filer | No 10-K filed 2026-03-05 cover |
| First EDGAR filing | 2020-01-16 (D) |
| SEC CIK | 1799448 |
| EIN | 000000000 |
| Phone | (800) 466-6059 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |